No Self-Editing: Biohacker Josiah Zayner Can’t Stop Living Out Loud
By Alex Lash,
Xconomy [cites CGS' Marcy Darnovsky]
| 03. 13. 2018
Gene editing has arrived. Of the various forms of the technology, CRISPR-Cas9 is the easiest to use, and it’s already showing up in summer camps and school science labs near you. That would be middle schools.
When everyone can edit an organism’s genes, how will the world change? Should we be worried? National security officials say yes.
Should we also be hopeful? A handful of drug companies have either begun or will soon begin human clinical studies of medicines that directly alter a patient’s genes.
Despite all this activity, biohackers like Josiah Zayner think the world is moving too slowly. They are pushing the boundaries of do-it-yourself gene editing, for medicine, for exploration, and for fun, through home CRISPR kits and audacious displays of self-experimentation. They have instant access to a global audience through social media, and they like to use it.
Zayner has publicly documented a few home-brewed experiments—including green-glowing beer and a replacement of his gut microbiome—and he has helped develop a do-it-yourself treatment for a Norwegian woman who was told she had incurable lung cancer. He...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...